Onyx Pharmaceuticals
South San Francisco
About Onyx Pharmaceuticals
Onyx Pharmaceuticals is a biopharmaceutical company committed to improving the lives of people with cancer. Their lead product is Nexavar (sorafenib), a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Total funding: $20.0M
- Funding stage: M&A
- Last round: Series Unknown (May 2002)
- Website: onyx-pharm.com
- Phone: +1 510-222-9700
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/onyx-pharmaceuticals-3191462 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.